ClinicalTrials.gg
RecruitingNCT05648552Updated Mar 23, 2023

Altered Structural-functional Connectivity Coupling on Chronic Subcortical Stroke

An observational study in Stroke and Motor Activity, sponsored by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School. Recruiting at 1 site in China. Open to participants aged 30 Years to 75 Years. Per ClinicalTrials.gov, last updated 2023-03-23.

Sponsored by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 4 months ago, but the record still lists the study as recruiting.
  • Started Jan 2022; still recruiting 4 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
70
Ages
30 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 613 studies in Stroke with a site in China — 242 open to participants now, 263 under way, 21 of them phase 3. Stroke · China.

Planned enrollment
158th of 180
70 · median 611
Started
2022
with 47 others
Observational
181 of 613
78 open now
Primary completion
2025-06
later than 48 of 262 live
Registered
320th of 613
by date

Among the 613 studies in Stroke with a site in China, this one is the 158th largest by planned enrollment of the 180 observational ones that give a count, is one of 48 that started in 2022, is one of 181 observational ones, reaches primary completion later than 48 of the 262 other live ones, and was the 320th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

242 of the 613 studies in Stroke with a site in China are open now. Recruiting first, the newest first:

237 more — sign in →

All 242 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 30 Years to 75 Years · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 613 studies in Stroke with a site in China, or all of them as a file.
02

Study summary

The current study aims to reveal the SC-FC coupling pattern and its relationship with motor function in post-stroke survivors with motor dysfunction by multimodal MRI.

Read the detailed description

Stroke is the leading cause of death and disability in China. Recently, many previous studies suggested exploring the functional reorganization of the motor function among post-stroke survivors is urgent to be solved in both clinical work and applied basic research. Investigating the structural connectivity (SC) of the brain could visualize the anatomical connections between different brain regions and exploring the functional connectivity (FC) could reveal the functional activity patterns of the human brain in resting- and task- states. Previous studies suggested that SC-FC coupling analysis may shed light on exploring biological markers for the assessment and treatment of motor deficits in post-stroke survivors. The current study aims to reveal the SC-FC coupling pattern and its relationship with motor function in post-stroke survivors with motor dysfunction by multimodal MRI.

03

Conditions studied

  • Stroke
  • Motor Activity

Keywords

  • Stroke
  • Motor dysfunction
  • MRI
  • structural connectivity
  • functional connectivity
04

Who can participate

Ages eligible
30 Years to 75 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

To recruit 35 chronic subcortical post-stroke participants with motor dysfunction and 35 well-matched healthy controls from the Department of Rehabilitation Medicine of Nanjing Drum Tower Hospital and the local communities.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Comply with the diagnostic criteria of "Stroke" in the 2010 "Guidelines for the Prevention and Treatment of Cerebrovascular Diseases in China," and confirmed by head CT or MRI.
  2. First onset unilateral subcortical stroke (basal ganglia, thalamus, internal capsule, corona radiata, lateral ventricles, etc.).
  3. Age ranged from 30 to 75 years old.
  4. Right-handedness before stroke.
  5. Greater than three months since stroke onset and Brunnstrom graded as III-VI; 6. The condition and vital signs are stable.
  1. Sign the form.

Exclusion criteria

Exclusion Criteria:

  1. Any for the MRI examination.
  2. History of other brain diseases and drug dependency.
  3. Unstable conditions or accompanied by malignant and rapidly progressing diseases, such as severe atrial fibrillation.
  4. Serious communication barriers, cognitive impairment, or cooperation with difficulties.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
70 participants (estimated)
Patient registry
No

Groups and cohorts

  • Stroke group

    Chronic subcortical stroke participants with motor dysfunction

  • Healthy controls group

    Well-matched healthy controls

06

What researchers measure

Primary outcomes

  1. Structural-functional Connectivity Coupling

    The coupling between structural connectivity and functional connectivity

    Time frame: Within 1 week after enrollment

  2. Fugl-Meyer Assessment

    Assessing the motor function in post-stroke participants

    Time frame: Within 1 week after enrollment

Secondary outcomes

  1. Chinese version of Modified Barthel Index

    Assessing the activities of daily living in post-stroke participants

    Time frame: Within 1 week after enrollment

  2. Broetz Hand Test

    Assessing the hemiplegic hand performance in post-stroke participants

    Time frame: Within 1 week after enrollment

  3. Placebo Questionnaire

    Self-evaluation of rehabilitation treatment in post-stroke participants

    Time frame: Within 1 week after enrollment

  4. Hamilton Depression Rating Scale

    Assessing the depression in post-stroke participants

    Time frame: Within 1 week after enrollment

  5. Chinese (Putonghua) Version of Oxford Cognitive Screen

    Assessing the cognition in post-stroke participants

    Time frame: Within 1 week after enrollment

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2022 (actual). Primary completion is estimated for Jun 2025, 41 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 5, 2022
First posted
Dec 13, 2022
StartActual
Jan 1, 2022
Primary completionEst.
Jun 30, 2025
CompletionEst.
Dec 31, 2025
Last update
Mar 23, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 23, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05648552
Responsible party
Sponsor
First posted
Dec 13, 2022
Start date
Jan 1, 2022
Primary completion
Jun 30, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Mar 23, 2023

Study contacts

Wenjun Hong
Contact
hongwenjun1989@126.com
+86 13851924571
Wenjun Hong
study chair · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion